Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Melatonin for Uveal Melanoma
NCT05502900Phase 3Recruiting
- Start
- Oct 2022
- Primary completion
- Jan 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in Uveal melanoma (UM). Started Oct 2022; status: recruiting.
02
Drugs
melatonin
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT05502900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05502900.